Amicus Therapeutics Inc FOLD

NAS: FOLD | ISIN: US03152W1099 3/07/2025

6,100 USD (+2,52%)

(+2,52%) 3/07/2025

Grafiek Amicus Therapeutics Inc

Grafiek Amicus Therapeutics Inc

1 dag1d 2,52%
1 week1w 6,46%
1 maand1m 2,35%
3 maanden3m -14,69%
6 maanden6m -34,41%
1 jaar1j -39,12%
5 jaar5j -60,90%

Amicus Therapeutics Inc in het nieuws

Toon enkel gratis nieuws

11 februari 2021 · Amicus’ AT-GAA Shows Clinically Meaningful & Significant Improvements in Both Musculoskeletal and Respiratory Measures in Late-Onset Pompe Disease Compared to Standard of Care in Pivotal Phase 3 PROPEL Study · Persbericht

8 februari 2021 · Amicus Therapeutics Announces Positive Initial Clinical Data for CLN3 Batten Disease Gene Therapy at the 17th Annual WORLDSymposium™ 2021 · Persbericht

8 februari 2021 · Amicus Therapeutics Presents Positive Preclinical Fabry Disease Gene Therapy Data at the 17th Annual WORLDSymposium™ 2021 · Persbericht

21 januari 2021 · Amicus Therapeutics Announces Presentations and Posters at the 17th Annual WORLDSymposium™ 2021 · Persbericht

Profiel Amicus Therapeutics Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.amicusrx.com

Hoofdzetel: Cranbury, New Jersey Verenigde Staten

CEO: John Crowley

Werknemers: 886

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe